Keros Therapeutics (KROS) Cash from Investing Activities (2019 - 2025)
Keros Therapeutics posted quarterly Cash from Investing Activities of -$134000.0 for Q4 2025, up 53.63% year-on-year from -$87220.7 in Q4 2024, and down 1.52% on a QoQ basis from -$132000.0 in Q3 2025.
Keros Therapeutics (KROS) has 7 years of Cash from Investing Activities data on file, last reported at -$134000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities rose 53.63% year-over-year to -$134000.0; the trailing twelve-month figure through Dec 2025 stood at -$1.6 million (up 19.68% YoY), and the FY2025 full-year result was -$1.6 million, up 19.68% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$134000.0, down from -$132000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$132000.0 in Q3 2025 and bottomed at -$1.1 million in Q1 2023.
- The 5-year median for Cash from Investing Activities is -$331000.0 (2022), against an average of -$410550.0.
- The widest annual swing landed in 2021, when Cash from Investing Activities slumped 1721.43%; it then surged 65.8% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$159000.0 in 2021, then tumbled by 120.75% to -$351000.0 in 2022, then sank by 54.13% to -$541000.0 in 2023, then soared by 46.58% to -$289000.0 in 2024, then jumped by 53.63% to -$134000.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$134000.0 (Q4 2025), -$132000.0 (Q3 2025), and -$720000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | -134,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -134,000.00 |
| Dec 31, 2025 | -134,000.00 |
| Sep 30, 2025 | -132,000.00 |
| Sep 30, 2025 | -132,000.00 |
| Jun 30, 2025 | -720,000.00 |
| Jun 30, 2025 | -720,000.00 |
| Mar 31, 2025 | -565,000.00 |
| Mar 31, 2025 | -565,000.00 |
| Dec 31, 2024 | -289,000.00 |
| Dec 31, 2024 | -289,000.00 |
| Sep 30, 2024 | -386,000.00 |
| Sep 30, 2024 | -386,000.00 |
| Jun 30, 2024 | -310,000.00 |
| Jun 30, 2024 | -310,000.00 |
| Mar 31, 2024 | -946,000.00 |
| Mar 31, 2024 | -946,000.00 |
| Dec 31, 2023 | -541,000.00 |
| Dec 31, 2023 | -541,000.00 |
| Sep 30, 2023 | -550,000.00 |
| Sep 30, 2023 | -550,000.00 |
| Jun 30, 2023 | -311,000.00 |
| Jun 30, 2023 | -311,000.00 |
| Mar 31, 2023 | -1.06 Mn |
| Mar 31, 2023 | -1.06 Mn |
| Dec 31, 2022 | -351,000.00 |
| Dec 31, 2022 | -351,000.00 |
| Sep 30, 2022 | -176,000.00 |
| Sep 30, 2022 | -176,000.00 |
| Jun 30, 2022 | -567,000.00 |
| Jun 30, 2022 | -567,000.00 |
| Mar 31, 2022 | -147,000.00 |
| Mar 31, 2022 | -147,000.00 |
| Dec 31, 2021 | -159,000.00 |
| Dec 31, 2021 | -159,000.00 |
| Sep 30, 2021 | -145,000.00 |
| Sep 30, 2021 | -145,000.00 |
| Jun 30, 2021 | -510,000.00 |
| Jun 30, 2021 | -510,000.00 |
| Mar 31, 2021 | -210,000.00 |
| Mar 31, 2021 | -210,000.00 |
| Dec 31, 2020 | -60,000.00 |
| Dec 31, 2020 | -60,000.00 |
| Sep 30, 2020 | -30,000.00 |
| Sep 30, 2020 | -30,000.00 |
| Jun 30, 2020 | -28,000.00 |
| Jun 30, 2020 | -28,000.00 |
| Mar 31, 2020 | -176,000.00 |
| Mar 31, 2020 | -176,000.00 |
| Dec 31, 2019 | -18,000.00 |
| Dec 31, 2019 | -18,000.00 |
| Sep 30, 2019 | -82,000.00 |
| Sep 30, 2019 | -82,000.00 |
| Jun 30, 2019 | -171,000.00 |
| Jun 30, 2019 | -171,000.00 |